Investor · 17 deals
Every published round MTPConnect took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted, and a place in one of its own programs is under Cohorts.
Everyone MTPConnect has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
| Member | Program | Announced | Cheque | Sources |
|---|---|---|---|---|
| Anaxis Pharma | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Argenica Therapeutics | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Aspecthera | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Atherid Therapeutics | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| CathRx Ltd | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Endo Axiom | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | ≤$500k | SmartCompany, Startup Daily |
| I D & E | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Inosi Therapeutics | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Nanomedx | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| ProGenis Pharmaceuticals | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Theia Medical | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Venstra Medical | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| Wavewise Analytics | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
| ZiP Diagnostics | Targeted Translation Research Accelerator (TTRA) Drugs and Devices program | 23 Jun 2025 | - | SmartCompany, Startup Daily |
Companies MTPConnect has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Anaxis Pharma | Targets cell death in diabetic kidney disease | 23 Jun 2025, Grant | 2 | 2 |
| Argenica Therapeutics | Developing ARG-007 to reduce disability in acute ischaemic stroke patients | 23 Jun 2025, Grant | 2 | 2 |
| Aspecthera | Novel eye-drop therapy for non-proliferative diabetic retinopathy | 23 Jun 2025, Grant | 2 | 2 |
| Atherid Therapeutics | First-in-class drug ATH01 designed to clear arterial plaque directly | 23 Jun 2025, Grant | 2 | 1 |
| CathRx Ltd | electroPulse pulsed field ablation system for atrial fibrillation | 23 Jun 2025, Grant | 2 | 2 |
| Cortical Dynamics | 25 Oct 2024, Accelerator | 1 | 0 | |
| Endo Axiom | oral Insulin Startup | 23 Jun 2025, Grant | 2 | 2 |
| I D & E | Ocular drug delivery system | 23 Jun 2025, Grant | 2 | 2 |
| Inosi Therapeutics | IRAP inhibitor for diabetic kidney disease | 23 Jun 2025, Grant | 2 | 2 |
| Nanomedx | Local regulation of inflammation for peripheral arterial disease | 23 Jun 2025, Grant | 2 | 2 |
| OncoRes Medical | Handheld probing device that assesses during surgery whether all breast cancer tissue has… | 2022, Series A | 1 | 0 |
| ProGenis Pharmaceuticals | Developing nucleic acid therapy for aortic stenosis | 23 Jun 2025, Grant | 2 | 2 |
| Proteomics International Pty Ltd | Developing Promarker Endo, a blood test for endometriosis diagnosis | 31 Oct 2024, Accelerator | 1 | 0 |
| Theia Medical | Hybrid 3D-printed intravascular imaging device for coronary artery disease | 23 Jun 2025, Grant | 2 | 2 |
| Venstra Medical | Temporary heart pump for patients in cardiogenic shock | 23 Jun 2025, Grant | 2 | 2 |
| Wavewise Analytics | Formerly Cyban, health analytics | 23 Jun 2025, Grant | 2 | 2 |
| ZiP Diagnostics | Point-of-care lateral flow test for prediction and early diagnosis of preeclampsia | 23 Jun 2025, Grant | 2 | 2 |
Fund closes reported for MTPConnect, as distinct from the investments it has made.
Companies MTPConnect has backed that another company then bought. An exit for the holding, not a deal MTPConnect did.
| Name | Role | Sources |
|---|---|---|
| Stuart Dignam | Chief Executive | Startup Daily (3 Sep 2025), SmartCompany, Startup Daily (23 Jun 2025), @AuManufacturing, Startup News (WA) |
Stories naming MTPConnect. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
MTPConnect's government-backed accelerator program has awarded $12.07 million in non-dilutive grants to 14 Australian drug and device companies, which will also receive mentoring and support from partners including CSL and Roche Diagnostics.
The University of Sydney has launched a $25 million pre-seed fund to back ventures spun out of its research, naming five initial investments across carbon capture, diabetes treatment, inhaled medicines and cardiovascular devices.
Navi Medical Technologies gained US FDA clearance for its Neonav catheter guidance system; the Melbourne firm, backed by Breakthrough Victoria, plans a capital raise later in 2025 to fund its American rollout.
Three Australian medtech firms, Cortical Dynamics, Microbio and Resonait Medical Technologies, join the Biomedical AI Sprints Accelerator run by ARM Hub and MTPConnect to apply AI and data across their medical products.
Weekly roundup of the outlet's most-read stories: grants for industry bodies, Space Machines' India mission funding, a plastics recycler's Melbourne factory, an Austal ownership debate, and a quantum growth centre.
Four not-for-profit bodies will share $6.9 million in grants to advise growing small businesses, as the Industry Growth Program opens applications for matched grants of $100,000 to $5 million.
Manufacturing briefs: Victoria backs a skills program, Titomic supplies an Air France subsidiary, a pool-technology firm hires a sales chief, Bod Science banks a tax rebate, and Amaero completes a placement.
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.
Diagnostic equipment maker LBT Innovations has received a federal government grant via the Medical Future Fund and MTPConnect to develop a smaller benchtop version of its APAS Independence instrument.
MTPConnect has awarded grants totalling almost $900,000 to three medtech projects under round four of its MRFF-backed BMTH program, benefiting two WA companies and one Victorian firm.
Peak Medical's acceptance into the Medical Device Partnering Program is announced, alongside MTPConnect launching a government-funded medtech commercialisation program with partners including Flinders University and Cicada Innovations.